The FDA has given 510(k) clearance for Eyenuk to market EyeArt, a screening system that uses artificial intelligence to automatically find vision-threatening diabetic retinopathy in diabetes patients in a single test. EyeArt can produce diagnostic outputs for each eye.
FDA OKs AI diabetic retinopathy screening from Eyenuk
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.